Apremilast 30 mg twice daily combined with dupilumab for the treatment of recalcitrant moderate-to-severe atopic dermatitis.

Autor:	Cunningham KN; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Alsukait S; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Cohen SR; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Learned C; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Gao DX; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Kachuk C; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Dumont N; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Zipeto A; Department of Dermatology, Tufts Medical Center, Massachusetts, Boston, USA., Rosmarin D; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Jazyk:	angličtina
Zdroj:	Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 Jun; Vol. 37 (6), pp. e765-e767. Date of Electronic Publication: 2023 Feb 08.
DOI:	10.1111/jdv.18906
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text